Imaging test for multiple myeloma using a new tracer
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests a new imaging method that uses a special tracer to find multiple myeloma cells in the body. It may help doctors see the disease more clearly and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have multiple myeloma, either newly diagnosed or after it has come back.
- You are willing and able to give written consent and attend follow-up visits.
- Your liver and kidney function are not severely impaired.
- You are not pregnant, planning to become pregnant, or breastfeeding, and you agree to use effective birth control if needed.
- You can lie flat for 30 minutes and do not have severe claustrophobia or other conditions that would make the scan difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new experimental drug called CM336 for people with multiple myeloma that has come back or stopped responding to standard treatments. The drug may work by helping your immune system attack and destroy myeloma cells. If you join, you will receive the study treatment and be closely monitored to see how well it works and how safe it is.
This study tests a newer type of PET/MR scan using a special tracer (68Ga-Pentixafor) to see if it can find lymphoma and multiple myeloma lesions better than the standard scan. The scan is painless and takes about 30 minutes, and it might help doctors see the cancer more clearly.
This study tests a new imaging method (PET-enabled dual-energy CT) to see if it can better show how multiple myeloma responds to CAR T-cell therapy. It may help doctors personalize treatment and catch changes early.
This trial tests a new imaging agent (a special dye) to see how it spreads in the body and whether it can help find multiple myeloma spots. It's not a treatment, but it may help doctors see the disease better.
This trial tests a new type of PET scan that uses a radioactive tracer (68Ga-BCMA) to find active multiple myeloma cells in your body. It may help doctors better detect and monitor the disease.
This trial tests a special imaging dye that targets a protein called BCMA on multiple myeloma cells. It may help doctors see and diagnose the disease more clearly during bone marrow or tissue biopsies.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.